Market Closed -
OTC Markets
14:21:45 2024-05-17 EDT
|
5-day change
|
1st Jan Change
|
0.04
USD
|
+9.33%
|
|
-14.71%
|
-4.99%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
19.4
|
10.27
|
5.563
|
1.952
|
1.399
|
0.9335
|
Enterprise Value (EV)
1 |
24.23
|
16.76
|
12.97
|
8.888
|
9.252
|
9.246
|
P/E ratio
|
11.7
x
|
2.74
x
|
-0.42
x
|
1.02
x
|
-0.29
x
|
4.21
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
17.1
x
|
10.1
x
|
5.4
x
|
2.19
x
|
2.04
x
|
4.76
x
|
EV / Revenue
|
21.3
x
|
16.5
x
|
12.6
x
|
9.99
x
|
13.5
x
|
47.1
x
|
EV / EBITDA
|
-8.94
x
|
-8.23
x
|
-8.07
x
|
-6.78
x
|
-5.73
x
|
-7.5
x
|
EV / FCF
|
-2.4
x
|
-1.42
x
|
1.36
x
|
-0.69
x
|
6.83
x
|
-2.42
x
|
FCF Yield
|
-41.6%
|
-70.3%
|
73.7%
|
-145%
|
14.6%
|
-41.3%
|
Price to Book
|
-0.87
x
|
-0.84
x
|
-0.24
x
|
-0.16
x
|
-0.1
x
|
-0.07
x
|
Nbr of stocks (in thousands)
|
11,054
|
12,507
|
14,264
|
14,723
|
20,423
|
22,173
|
Reference price
2 |
1.755
|
0.8212
|
0.3900
|
0.1326
|
0.0685
|
0.0421
|
Announcement Date
|
4/19/19
|
5/13/20
|
3/31/21
|
4/18/22
|
4/27/23
|
4/16/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1.137
|
1.014
|
1.03
|
0.8899
|
0.6854
|
0.1963
|
EBITDA
1 |
-2.709
|
-2.037
|
-1.606
|
-1.311
|
-1.615
|
-1.233
|
EBIT
1 |
-2.871
|
-2.265
|
-1.748
|
-1.43
|
-1.637
|
-1.244
|
Operating Margin
|
-252.56%
|
-223.3%
|
-169.78%
|
-160.67%
|
-238.84%
|
-633.96%
|
Earnings before Tax (EBT)
1 |
4.537
|
7.522
|
-12.3
|
10.18
|
-3.638
|
1.66
|
Net income
1 |
4.747
|
7.804
|
-12.1
|
9.724
|
-3.577
|
1.61
|
Net margin
|
417.68%
|
769.44%
|
-1,175.16%
|
1,092.74%
|
-521.84%
|
820.04%
|
EPS
2 |
0.1500
|
0.3000
|
-0.9200
|
0.1300
|
-0.2400
|
0.009999
|
Free Cash Flow
1 |
-10.09
|
-11.78
|
9.56
|
-12.87
|
1.354
|
-3.821
|
FCF margin
|
-887.35%
|
-1,161.31%
|
928.61%
|
-1,446.05%
|
197.62%
|
-1,946.5%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/19/19
|
5/13/20
|
3/31/21
|
4/18/22
|
4/27/23
|
4/16/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
4.83
|
6.49
|
7.4
|
6.94
|
7.85
|
8.31
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-1.781
x
|
-3.188
x
|
-4.608
x
|
-5.291
x
|
-4.863
x
|
-6.744
x
|
Free Cash Flow
1 |
-10.1
|
-11.8
|
9.56
|
-12.9
|
1.35
|
-3.82
|
ROE (net income / shareholders' equity)
|
-16.3%
|
-40.9%
|
64%
|
-47.8%
|
23.3%
|
-9.81%
|
ROA (Net income/ Total Assets)
|
-87.8%
|
-53.4%
|
-44.1%
|
-46.2%
|
-84.8%
|
-147%
|
Assets
1 |
-5.406
|
-14.61
|
27.43
|
-21.04
|
4.217
|
-1.096
|
Book Value Per Share
2 |
-2.010
|
-0.9700
|
-1.640
|
-0.8500
|
-0.7000
|
-0.6200
|
Cash Flow per Share
2 |
0.0100
|
0.0100
|
0
|
0.0400
|
0
|
0
|
Capex
1 |
0.2
|
0.02
|
-
|
0.01
|
-
|
-
|
Capex / Sales
|
17.18%
|
1.94%
|
-
|
1.32%
|
-
|
-
|
Announcement Date
|
4/19/19
|
5/13/20
|
3/31/21
|
4/18/22
|
4/27/23
|
4/16/24
|
|
1st Jan change
|
Capi.
|
---|
| -4.99% | 887K | | -37.75% | 341M | | -.--% | 339M | | +52.26% | 299M | | +35.05% | 279M | | +57.56% | 206M | | +52.17% | 138M | | +158.04% | 137M | | -28.57% | 122M | | +34.62% | 118M |
Medical Farming
|